Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Joslin Diabetes Center, Boston, Massachusetts, USA.
Nature medicine (Impact Factor: 27.36). 09/2009; 15(8):930-9. DOI: 10.1038/nm.2002
Source: PubMed


Obesity is accompanied by chronic, low-grade inflammation of adipose tissue, which promotes insulin resistance and type-2 diabetes. These findings raise the question of how fat inflammation can escape the powerful armamentarium of cells and molecules normally responsible for guarding against a runaway immune response. CD4(+) Foxp3(+) T regulatory (T(reg)) cells with a unique phenotype were highly enriched in the abdominal fat of normal mice, but their numbers were strikingly and specifically reduced at this site in insulin-resistant models of obesity. Loss-of-function and gain-of-function experiments revealed that these T(reg) cells influenced the inflammatory state of adipose tissue and, thus, insulin resistance. Cytokines differentially synthesized by fat-resident regulatory and conventional T cells directly affected the synthesis of inflammatory mediators and glucose uptake by cultured adipocytes. These observations suggest that harnessing the anti-inflammatory properties of T(reg) cells to inhibit elements of the metabolic syndrome may have therapeutic potential.

Download full-text


Available from: Jongsoon Lee,
    • "In over-expressing RBP4 (ox-RBP4) mice, the AT show increasing of both CD11c+ and CD206+ macrophage populations with an unexpected, pro-inflammatory cytokines produced by CD206+ and expression of elevated amounts of co-stimulatory molecules required for CD4 T cell activation, typical behavior of CD11c+ macrophages [13]. Macrophages activation is only part of the immune response that causes insulin resistance, there is also the recruitment of T cells to AT [14] [15] [16]. RBP4 increases the capacity of macrophages to induce a CD4 T cell immune response. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity, insulin resistance, metabolic syndrome and type 2 diabetes have reached epidemic proportions, from here the term: diabesity. Vitamin A is delivered by a specific binding protein called retinol-binding protein 4 (RBP4) a soluble protein, emerging to have a role in insulin resistance, the major cause of diabetes highly associated with adipose tissue inflammation and obesity with action. RBP4, interacts with two receptors, the Toll-like receptor 4 (TLR4) and the plasma membrane protein called stimulated by retinoic acid 6 (STRA6) leading to the activation of c-Jun N-terminal protein kinase (JNK) pathways and JAK2/STAT5 cascade, respectively. Both mechanism sustain insulin resistance. In effect, ablation of STRA6 protects mice from RBP4-induced suppression of insulin signaling. In addition, mice harboring deletion of a specific chaperon for retinol, show infiltration of α-cells in the core of pancreatic islets, where usually only β-cells reside, showing a pre-diabetic like phenotype. Not only proteins in vitamin A shuttle and signaling are emerging in diabesity, recently the discovery of 9cis retinoic acid (9cRA) having effects in controlling glucose levels opened a new scenario. So far, only pancreas β-cells have been shown to synthesize it, and high levels of 9cRA correlate with obesity mice models. In this article, we summarize the recent literature present on this topic raising the hypothesis.
    Mini Reviews in Medicinal Chemistry 07/2015; · 2.90 Impact Factor
  • Source
    • "Moreover, AT infiltration by T and B cells increases the inflammatory state in obese mice, leading to insulin resistance (Nishimura et al., 2009; Winer et al., 2011). Loss-of-function experiments demonstrated an imbalance between regulatory and effector T cells which is crucial in this inflammation (Feuerer et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: A high-fat diet (HFD) induces metabolic disease and low-grade metabolic inflammation in response to changes in the intestinal microbiota through as-yet-unknown mechanisms. Here, we show that a HFD-derived ileum microbiota is responsible for a decrease in Th17 cells of the lamina propria in axenic colonized mice. The HFD also changed the expression profiles of intestinal antigen-presenting cells and their ability to generate Th17 cells in vitro. Consistent with these data, the metabolic phenotype was mimicked in RORγt-deficient mice, which lack IL17 and IL22 function, and in the adoptive transfer experiment of T cells from RORγt-deficient mice into Rag1-deficient mice. We conclude that the microbiota of the ileum regulates Th17 cell homeostasis in the small intestine and determines the outcome of metabolic disease. Copyright © 2015 Elsevier Inc. All rights reserved.
    Cell metabolism 07/2015; 22(1):100-12. DOI:10.1016/j.cmet.2015.06.001 · 17.57 Impact Factor
    • "For example, binding of leptin, an adipocyte derived cytokine to its receptor expressed on Treg suppresses Treg proliferation (De Rosa et al., 2007) and links regulation of metabolism by adipokines to Treg biology. Interstingly, various recent publications also highlighted the therapeutic potential of Treg to limit adipositasand metabolic dysfunction-associated inflammation (Feuerer et al., 2009; Winer et al., 2009; Eller et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Immune escape is a hallmark of cancer. Regulatory T cells (Treg) have been described to maintain peripheral tolerance. The role of Treg in cancer is ambiguous, as they are central inhibitory regulators in solid tumors, whereas during inflammation-driven tumorigenesis they prevent cancer initiation by restraining inflammation. As a consequence, under conditions with chronic inflammation that may initiate malignant transformation, application rather than depletion of Treg may be helpful. In solid tumors, however, the success story of immune-activating antibodies targeting checkpoint molecules of T cell activation fuels the hope that Treg inactivation or depletion may additionally boost anti-tumor immune response. In this review we summarize important aspects on the dual role of Treg in cancer to provide a rationale for future Treg targeting attempts. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
    Journal of Cellular Physiology 04/2015; 230(11). DOI:10.1002/jcp.25016 · 3.84 Impact Factor
Show more